TABLE 2.

Rosiglitazone example: (a) a summary of FlexB estimates for myocardial infrarction (MI) and cardiovascular death (CVD); (b) comparison of different methods in estimating θ₀ and τ² for MI and CVD.

	MI				CVD
	Mean	SE	Median	95% C.I.	Mean	SE	Median	95% C.I.
θ 0	0.247	0.147	0.241	(−0.054,0.579)	0.160	0.232	0.144	(−0.342,0.687)
τ 2	0.058	0.075	0.033	(0.001,0.201)	0.117	0.188	0.052	(0.002,0.454)
μ 0	−5.761	0.224	−5.754	(−6.225,−5.336)	−6.633	0.307	−6.612	(−7.280,−6.087)
σ 2	1.008	0.325	0.957	(0.454,1.543)	1.535	0.623	1.429	(0.547,2.860)
(a)

	θ 0				τ 2
	MI	p-value	CVD	p-value		MI	CVD
SA	0.030	0.446	−0.063	0.395	DSL	0	0
DSL	0.295	0.006	0.118	0.184	DSK	0	0
EL	0.159	0.081	−0.059	0.325	PM	0	0
MH	0.250	0.015	0.026	0.422	IPM	0	0
MUE	0.071	0.268	−0.032	0.402	GLMM	0	0
GLMM	0.226	0.061	0.007	0.962	BAYES	0.042	0.024
SGSwgt	0.248	0.016	0.036	0.391	FlexB	0.033	0.052
BAYES	0.175	*	0.137	*
HTE-Beta	0.220	*	0.297	*
FlexB	0.247	*	0.160	*
(b)